Identifying dacs as an agency that understands the health and wellness category as well as the alternative categories including psychedelics and cannabis is key to helping Psyched build a fulsome go-to-market strategy.

This contract will be divided into 3 objectives over a period of 2 years to further preliminary findings indicating anti-inflammatory and antioxidant properties in addition to the study of potential neuroprotective roles of the AME-1 extract.